Trials / Unknown
UnknownNCT05066022
A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma
Open Label, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of CT0590 Chimeric Antigen Receptor T Cell （CAR T）in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- The First Affiliated Hospital of Soochow University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single arm study to evaluate the safety and tolerability of treatment with CT0590 CAR T in patients with relapsed and/or refractory multiple myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CT0590 CAR T Cells | Dose-escalated CAR T cells infusion |
Timeline
- Start date
- 2021-10-28
- Primary completion
- 2022-08-30
- Completion
- 2024-07-29
- First posted
- 2021-10-04
- Last updated
- 2021-11-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05066022. Inclusion in this directory is not an endorsement.